Open AccessNoncirrhotic portal hypertension: An under-reported late adverse event of SIRT in metastatic colorectal cancer patients
Author(s) -
L. Gutiérrez,
S. Méndez,
Mercedes Mitjavila,
Elba Llop,
Clara Salas,
Ana Ruiz-Casado
Publication year - 2019
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_1398_16
Subject(s) - oxaliplatin , colorectal cancer , medicine , incidence (geometry) , selective internal radiation therapy , oncology , adverse effect , portal hypertension , cancer , gastroenterology , physics , hepatocellular carcinoma , optics , cirrhosis
Selective internal radiation therapy (SIRT) is increasingly used in different scenarios. Although portal hypertension (PHT) has been described as a nonclinically relevant finding after SIRT, its real incidence could have been neglected due to the nature of the diseases for which SIRT is indicated.